The article offers information about the real-world effectiveness of antipsychotics (AP) on the rate of transition to psychosis. It mentions that understanding of the risks and benefits of AP as essential for prescribers and individuals at clinical high risk. It discusses that increase the risk of symptomatically overt transition to psychosis despite the pharmacologic prescription.